Submucosal lymphatic cyst of the stomach

Kim, Young Jun; Chung, Kyung Sup; Chung, Jae Bock; Lee, Sang In; Park, In Suh; Choi, Heung Jae; Lee, Kyung Sik; Cho, Nam Hoon; Park, Chan Il

doi:10.3349/ymj.1989.30.4.387

Cited by 4 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, after reading the full text, seven quasi-RCTs were excluded. Twenty-one articles describing 22 RCTs met the inclusion criteria and were included in the quantitative synthesis meta-analysis (Avidan et al, 2001;Lamouliatte et al, 2003;Miwa et al, 2003;Neri et al, 2003;Romano et al, 2003;Marzio et al, 2006;Furuta et al, 2007;Bontems et al, 2011;Park et al, 2014;Dong et al, 2015;Zhang et al, 2015;Zhou et al, 2016;Liou et al, 2018b;Chen et al, 2019;Fan et al, 2019;Ong et al, 2019;Delchier et al, 2020;Ji et al, 2020;Kim et al, 2020;Pan et al, 2020;Perkovic et al, 2021). Figure 1…”

Section: Study Selectionmentioning

confidence: 99%

Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis

Liao

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

Background: Due to an increase in drug resistance, the eradication rate of H. pylori with empirical therapy has declined. Tailored therapy has been proposed as an alternative to standard empirical treatments. The necessity of personalized eradication therapy remains unclear. The aim of this study was to determine whether tailored therapy is superior to empirical therapy for H. pylori infection.Methods: We searched for eligible randomized controlled trials in the PubMed, Embase (Ovid), Wanfang, and Cochrane Central Register of Controlled Trials databases up to 10 December 2021. A random effects model comparing pooled relative risks (RRs) with 95% confidence intervals (CIs) was applied in the meta-analysis.Results: Twenty-one studies were included in the meta-analysis. In the first-line treatment, tailored therapy was more effective than empirical therapy (RR, 1.14 [95% CI, 1.08–1.21], I2 = 72.2%). In the second-line therapy setting, the results did not reveal significant differences between the two treatments (RR, 1.05 [95% CI, 0.84–1.30], I2 = 80.6%). A similar result was observed in mixed second- and third-line treatments (RR, 1.03 [95% CI, 0.96–1.11], I2 = 0.0%). Regarding adverse events, no significant differences were found between the two treatments (RR, 0.90 [95% CI, 0.80–1.01], I2 = 35.7%). Most of the results were highly heterogeneous.Conclusion: A tailored approach might provide a better eradication rate than empirical methods in first-line treatment. There might be no obvious advantage in second-line or mixed second- and third-line treatments third-line treatment. Due to the high heterogeneity, the results should be interpreted with caution. Further clinical studies are needed and justified.

show abstract

Section: Study Selectionmentioning

confidence: 99%

Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis

Liao

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

“…Yoshinori et al in 1995 reported the EUS find-English literature. [3][4][5][6][7][8][9][10][11] However, a total of 62 cases of lymphangioma in the stomach have been ings of a colonic lymphangioma. An anechoic lesion with septa in the submucosal layer, similar reported in Japan.…”

Section: Case Reportmentioning

confidence: 99%

“…However, other lesions such as leiomyoma, included aspiration, 15,16 local excision, 5,7,11,15,16 and gastro-enterostomy. 4 10 pointed out that a lymphangioma is compressible with biopsy forceps and usually gastric adenocarcinomas. 15 Whether this is an incidental finding or a true association is still in has a translucent wall.…”

Section: Case Reportmentioning

confidence: 99%